Apolipoprotein E ε 4 allele and nephrotic glomerular diseases in children

被引:14
作者
Asami, T [1 ]
Ciomartan, T [1 ]
Hayakawa, H [1 ]
Uchiyama, M [1 ]
Tomisawa, S [1 ]
机构
[1] Niigata Univ, Sch Med, Dept Pediat, Niigata, Japan
关键词
apolipoprotein E phenotype; nephrotic syndrome; focal segmental glomerulosclerosis;
D O I
10.1007/s004670050599
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperlipidemia is a well-recognized complication of the nephrotic syndrome and is a factor contributing to the progression of the initial glomerular injury and the development of glomerulosclerosis. Apolipoprotein E (apoE) is a plasma protein and apoE epsilon 4 allele is associated with higher plasma cholesterol levels. With this in mind, we studied apoE phenotypes and alleles in children with nephrotic glomerular diseases (NGD, n=29), including idiopathic nephrotic syndrome (n=16), membranoproliferative glomerulonephritis (n=7), and focal segmental glomerulosclerosis (FSGS, n=6). Children with NGD had a higher epsilon 4 allele frequency (20.7%) than controls (10.8%), and those with FSGS had both higher apoE4/3 (66.7%) and epsilon 4 allele (33.3%) frequencies than controls (20.4% and 10.8%, respectively). In IgA nephropathy (n=30, disease controls), no significant association with specific apoE was found. Further studies are needed to clarify the significance of the observed high frequencies of apoE epsilon 4 allele in children with NGD and apoE4/3 phenotype distribution in FSGS.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 24 条
[1]   HYPERLIPEMIA IN UNTREATED NEPHROTIC SYNDROME, INCREASED PRODUCTION OR DECREASED REMOVAL [J].
CHAN, MK ;
PERSAUD, JW ;
RAMDIAL, L ;
VARGHESE, Z ;
SWENY, P ;
MOORHEAD, JF .
CLINICA CHIMICA ACTA, 1981, 117 (03) :317-323
[2]  
CHURG J, 1970, LANCET, V1, P1299
[3]  
Cooper AD, 1997, J LIPID RES, V38, P2173
[4]   PROTEINURIA, NOT ALTERED ALBUMIN METABOLISM, AFFECTS HYPERLIPIDEMIA IN THE NEPHROTIC RAT [J].
DAVIES, RW ;
STAPRANS, I ;
HUTCHISON, FN ;
KAYSEN, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :600-605
[5]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[6]  
DAVIGNON J, 1991, NUTR METAB CARDIOVAS, V1, P53
[7]  
Diamond J R, 1989, Am J Med, V87, p25N
[8]   ROLE OF APOLIPOPROTEIN-E IN THE LIPOLYTIC CONVERSION OF BETA-VERY- LOW-DENSITY LIPOPROTEINS TO LOW-DENSITY LIPOPROTEINS IN TYPE-III HYPERLIPOPROTEINEMIA [J].
EHNHOLM, C ;
MAHLEY, RW ;
CHAPPELL, DA ;
WEISGRABER, KH ;
LUDWIG, E ;
WITZTUM, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (17) :5566-5570
[9]   ABNORMALITIES OF LIPOPROTEIN METABOLISM IN PATIENTS WITH THE NEPHROTIC SYNDROME [J].
JOVEN, J ;
VILLABONA, C ;
VILELLA, E ;
MASANA, L ;
ALBERTI, R ;
VALLES, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (09) :579-584
[10]   LIPIDS AND THE KIDNEY [J].
KEANE, WF ;
MADIAS, NE ;
HARRINGTON, JT ;
PEREIRA, B ;
SINGH, A ;
LAFAYETTE, R ;
NEURINGER, J ;
NATOV, SN .
KIDNEY INTERNATIONAL, 1994, 46 (03) :910-920